Details for Patent: 11,129,869
✉ Email this page to a colleague
Which drugs does patent 11,129,869 protect, and when does it expire?
Patent 11,129,869 protects IMCIVREE and is included in one NDA.
This patent has thirty-one patent family members in seventeen countries.
Summary for Patent: 11,129,869
| Title: | Pharmaceutical compositions |
| Abstract: | The present invention relates to an ionic complex comprising a cationic polypeptide and an anionic excipient selected from: a PEG-carboxylic acid; a fatty acid having 10 or more carbon atoms; an anionic phospholipid; and a combination thereof. The invention also relates to a pharmaceutical composition comprising the ionic complex of the invention and a pharmaceutically acceptable carrier. The cationic polypeptide of the ionic complex has pharmacological activity and the complex can provide a more desirable pharmacokinetic profile for the cationic polypeptide of the complex as compared to the cationic polypeptide alone following administration. As such, the invention also relates to the use of the ionic complex and pharmaceutical composition comprising same to treat a subject suffering from a disease or disorder that is responsive to the cationic polypeptide of the ionic complex. |
| Inventor(s): | Sharma; Shubh (Cranbury, NJ), Van Der Ploeg; Leonardus H. T. (Newton, MA), Henderson; Bart (Belmont, MA) |
| Assignee: | RHYTHM PHARMACEUTICALS, INC. (Boston, MA) |
| Application Number: | 14/775,911 |
|
Patent Claim Types: see list of patent claims | Composition; Compound; Process; |
Drugs Protected by US Patent 11,129,869
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Rhythm | IMCIVREE | setmelanotide acetate | SOLUTION;SUBCUTANEOUS | 213793-001 | Nov 25, 2020 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
Foreign Priority and PCT Information for Patent: 11,129,869
| PCT Information | |||
| PCT Filed | March 14, 2014 | PCT Application Number: | PCT/US2014/029421 |
| PCT Publication Date: | September 18, 2014 | PCT Publication Number: | WO2014/144842 |
International Family Members for US Patent 11,129,869
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Australia | 2014228460 | ⤷ Try a Trial | |||
| Australia | 2019200101 | ⤷ Try a Trial | |||
| Australia | 2021202699 | ⤷ Try a Trial | |||
| Australia | 2023204625 | ⤷ Try a Trial | |||
| Brazil | 112015023409 | ⤷ Try a Trial | |||
| Canada | 2906782 | ⤷ Try a Trial | |||
| Canada | 3209602 | ⤷ Try a Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
